Fibrin acts as biomimetic niche inducing both differentiation and stem cell marker expression of early human endothelial progenitor cells

Cell Proliferation

Volumn 44, Issue 1, 2011, Pages 33-48

  Barsotti, M C ^a   Magera, A ^a   Armani, C ^a   Chiellini, F ^a   Felice, F ^a   Dinucci, D ^a   Piras, A M ^a   Minnocci, A ^b   Solaro, R ^a   Soldani, G ^c   Balbarini, A ^a   Di Stefano, R ^a  

^a UNIVERSITY OF PISA   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMIMETIC MATERIAL; FIBRIN; FIBRINOGEN; FIBRONECTIN; MATRIGEL; OCTAMER TRANSCRIPTION FACTOR 4; THROMBIN; TRANSCRIPTION FACTOR NANOG;

ANGIOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL POPULATION; CELL VIABILITY; ENDOTHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; STEM CELL;

BIOCOMPATIBLE MATERIALS; BIOLOGICAL MARKERS; BIOMIMETIC MATERIALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM; FIBRIN; FIBRINOGEN; FIBRONECTINS; HOMEODOMAIN PROTEINS; HUMANS; OCTAMER TRANSCRIPTION FACTOR-3; POROSITY; STEM CELLS; THROMBIN;

EID: 78650690629     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2010.00715.x     Document Type: Article

References (59)

1. Hamdi H, Furuta A, Bellamy V, Bel A, Puymirat E, Peyrard S et al. (2009) Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison Ann. Thorac. Surg. 87, 1196-1203.
2. Shaikh FM, Callanan A, Kavanagh EG, Burke PE, Grace PA, McGloughlin TM (2008) Fibrin: a natural biodegradable scaffold in vascular tissue engineering. Cells Tissues Organs 188, 333-346.
3. Janmey PA, Winer JP, Weisel JW (2009) Fibrin gels and their clinical and bioengineering applications. J. R. Soc. Interface 6, 1-10.
4. Nakatsu MN, Sainson RC, Aoto JN, Taylor KL, Aitkenhead M, Perez-del-Pulgar S et al. (2003) Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1. Microvasc. Res. 66, 102-112.
5. Cox S, Cole M, Tawil B (2004) Behavior of human dermal fibroblasts in three-dimensional fibrin clots: dependence on fibrinogen and thrombin concentration. Tissue Eng. 10, 942-954.
6. Horch RE, Bannasch H, Kopp J, Andree C, Stark GB (1998) Single-cell suspensions of cultured human keratinocytes in fibrin-glue reconstitute the epidermis. Cell Transplant. 7, 309-317.
7. Ye Q, Zund G, Benedikt P, Jockenhoevel S, Hoerstrup SP, Sakyama S et al. (2000) Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur. J. Cardiothorac. Surg. 17, 587-591.
8. Bensaid W, Triffitt JT, Blanchat C, Oudina K, Sedel L, Petite H (2003) A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 24, 2497-2502.
9. Fan CL, Gao PJ, Gu YJ, Tang XF, Liu JJ, Wei J et al. (2006) Therapeutic angiogenesis by intramuscular injection of fibrin particles into ischaemic hind limbs. Clin. Exp. Pharmacol. Physiol. 33, 617-622.
10. Christman KL, Vardanian AJ, Fang Q, Sievers RE, Fok HH, Lee RJ (2004) Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J. Am. Coll. Cardiol. 44, 654-660.
11. Wong C, Inman E, Spaethe R, Helgerson S (2003)) Fibrin-based biomaterials to deliver human growth factors. Thromb. Haemost. 89, 573-582.
12. Sahni A, Francis CW (2000) Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 96, 3772-3778.
13. Mittermayr R, Morton T, Hofmann M, Helgerson S, Van Griensven M, Redl H (2008) Sustained (rh)VEGF(165) release from a sprayed fibrin biomatrix induces angiogenesis, up-regulation of endogenous VEGF-R2, and reduces ischemic flap necrosis. Wound Repair Regen. 16, 542-550.
14. Briganti E, Spiller D, Mirtelli C, Kull S, Counoupas C, Losi P et al. (2010) A composite fibrin-based scaffold for controlled delivery of bioactive pro-angiogenetic growth factors. J. Control Release 142, 14-21.
15. Losi P, Briganti E, Magera A, Spiller D, Ristori C, Battolla B et al. (2010) Tissue response to poly(ether)urethane-polydimethylsiloxane-fibrin composite scaffolds for controlled delivery of pro-angiogenic growth factors. Biomaterials 31, 5336-5344.
16. Asahara T, Murohara T, Sullivan A, Silver M, Van der Zee R, Li T et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967.
17. Balbarini A, Barsotti MC, Di Stefano R, Leone A, Santoni T (2007) Circulating endothelial progenitor cells characterization, function and relationship with cardiovascular risk factors. Curr. Pharm. Des. 13, 1699-1713.
18. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK et al. (2004) Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 24, 288-293.
19. Rehman J, Li J, Orschell CM, March KL (2003) Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107, 1164-1169.
20. Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM et al. (2005) Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell. Cardiol. 39, 733-742.
21. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M et al. (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA 97, 3422-3427.
22. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F et al. (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109, 1801-1809.
23. Fuchs S, Hermanns MI, Kirkpatrick CJ (2006) Retention of a differentiated endothelial phenotype by outgrowth endothelial cells isolated from human peripheral blood and expanded in long-term cultures. Cell Tissue Res. 326, 79-92.
24. Deschaseaux F, Selmani Z, Falcoz PE, Mersin N, Meneveau N, Penfornis A et al. (2007) Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors. Eur. J. Pharmacol. 562, 111-118.
25. Gulati R, Jevremovic D, Peterson TE, Chatterjee S, Shah V, Vile RG et al. (2003) Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ. Res. 93, 1023-1025.
26. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C et al. (2004) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J. Am. Coll. Cardiol. 44, 1690-1699.
27. Wang XX, Zhang FR, Shang YP, Zhu JH, Xie XD, Tao QM et al. (2007) Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J. Am. Coll. Cardiol. 49, 1566-1571.
28. Zhu JH, Wang XX, Zhang FR, Shang YP, Tao QM, Zhu JH et al. (2008) Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: open-label pilot study. Pediatr. Transplant. 12, 650-655.
29. Di Stefano R, Santoni T, Barsotti MC, Armani C, Chifenti B, Guida C et al. (2002) Different growth conditions for peripheral blood endothelial progenitors. Cardiovasc. Radiat. Med. 3, 172-175.
30. Sidelmann JJ, Gram J, Jespersen J, Kluft C (2000) Fibrin clot formation and lysis: basic mechanisms. Semin. Thromb. Hemost. 26, 605-618.
31. Eyrich D, Brandl F, Appel B, Wiese H, Maier G, Wenzel M et al. (2007) Long-term stable fibrin gels for cartilage engineering. Biomaterials 28, 55-65.
32. Ho W, Tawil B, Dunn JC, Wu BM (2006) The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure. Tissue Eng. 12, 1587-1595.
33. Finkenzeller G, Torio-Padron N, Momeni A, Mehlhorn AT, Stark GB (2007) In vitro angiogenesis properties of endothelial progenitor cells: a promising tool for vascularization of ex vivo engineered tissues. Tissue Eng. 13, 1413-1420.
34. Punshon G, Sales KM, Vara DS, Hamilton G, Seifalian AM (2008) Assessment of the potential of progenitor stem cells extracted from human peripheral blood for seeding a novel vascular graft material. Cell Prolif. 41, 321-335.
35. Sreerekha PR, Krishnan LK (2006) Cultivation of endothelial progenitor cells on fibrin matrix and layering on dacron/polytetrafluoroethylene vascular grafts. Artif. Organs 30, 242-249.
36. Smadja DM, Basire A, Amelot A, Conte A, Bieche I, Le Bonniec BF et al. (2008) Thrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells. J. Cell. Mol. Med. 12, 975-986.
37. Thebaud NB, Bareille R, Remy M, Bourget C, Daculsi R, Bordenave L (2010) Human progenitor-derived endothelial cells vs. venous endothelial cells for vascular tissue engineering: an in vitro study. J. Tissue Eng. Regen. Med. 4, 473-484.
38. Prasad Chennazhy K, Krishnan LK (2005) Effect of passage number and matrix characteristics on differentiation of endothelial cells cultured for tissue engineering. Biomaterials 26, 5658-5667.
39. Sreerekha PR, Divya P, Krishnan LK (2006) Adult stem cell homing and differentiation in vitro on composite fibrin matrix. Cell Prolif. 39, 301-312.
40. Discher DE, Janmey P, Wang YL (2005) Tissue cells feel and respond to the stiffness of their substrate. Science 310, 1139-1143.
41. Ferrenq I, Tranqui L, Vailhe B, Gumery PY, Tracqui P (1997) Modelling biological gel contraction by cells: mechanocellular formulation and cell traction force quantification. Acta Biotheor. 45, 267-293.
42. Nehls V, Drenckhahn D (1995) A microcarrier-based cocultivation system for the investigation of factors and cells involved in angiogenesis in three-dimensional fibrin matrices in vitro. Histochem. Cell Biol. 104, 459-466.
43. Weisel JW (2004) The mechanical properties of fibrin for basic scientists and clinicians. Biophys. Chem. 112, 267-276.
44. Liu W, Jawerth LM, Sparks EA, Falvo MR, Hantgan RR, Superfine R et al. (2006) Fibrin fibers have extraordinary extensibility and elasticity. Science 313, 634.
45. Guthold M, Liu W, Sparks EA, Jawerth LM, Peng L, Falvo M et al. (2007) A comparison of the mechanical and structural properties of fibrin fibers with other protein fibers. Cell Biochem. Biophys. 49, 165-181.
46. Eyrich D, Gopferich A, Blunk T (2006) Fibrin in tissue engineering. Adv. Exp. Med. Biol. 585, 379-392.
47. Akpalo E, Larreta-Garde V (2010) Increase of fibrin gel elasticity by enzymes: a kinetic approach. Acta Biomater. 6, 396-402.
48. Cho HJ, Lee N, Lee JY, Choi YJ, Ii M, Wecker A et al. (2007) Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J. Exp. Med. 204, 3257-3269.
49. Zhang Y, Ingram DA, Murphy MP, Saadatzadeh MR, Mead LE, Prater DN et al. (2009) Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells. Am. J. Physiol. Heart Circ. Physiol. 296, H1675-H1682.
50. Morimoto H, Takahashi M, Izawa A, Ise H, Hongo M, Kolattukudy PE et al. (2006) Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction. Circ. Res. 99, 891-899.
51. Jensen T, Kierulf P, Sandset PM, Klingenberg O, Joo GB, Godal HC et al. (2007) Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells. Thromb. Haemost. 97, 822-829.
52. Niwa H, Miyazaki J, Smith AG (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24, 372-376.
53. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S et al. (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655.
54. Romagnani P, Annunziato F, Liotta F, Lazzeri E, Mazzinghi B, Frosali F et al. (2005) CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ. Res. 97, 314-322.
55. Baal N, Reisinger K, Jahr H, Bohle RM, Liang O, Munstedt K et al. (2004) Expression of transcription factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood. Thromb. Haemost. 92, 767-775.
56. Kucia M, Wu W, Ratajczak MZ (2007) Bone marrow-derived very small embryonic-like stem cells: their developmental origin and biological significance. Dev. Dyn. 236, 3309-3320.
57. Song N, Jia XS, Jia LL, Ma XB, Li F, Wang EH et al. (2009) Expression and role of Oct3/4, Nanog and Sox2 in regeneration of rat tracheal epithelium. Cell Prolif. 43, 49-55.
58. Ruger BM, Breuss J, Hollemann D, Yanagida G, Fischer MB, Mosberger I et al. (2008) Vascular morphogenesis by adult bone marrow progenitor cells in three-dimensional fibrin matrices. Differentiation 76, 772-783.
59. Gauthaman K, Venugopal JR, Yee FC, Peh GS, Ramakrishna S, Bongso A (2009) Nanofibrous substrates support colony formation and maintain stemness of human embryonic stem cells. J. Cell. Mol. Med. 13, 3475-3484.